<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="various cell lines and in rhesus macaques. Interferon-alpha 2b and" exact="ribavirin" post="have a synergistic effect on SARS-CoV-1 and MERS-CoV in"/>
 <result pre="releases specific inflammatory and acute phase response biomolecules (aspartate transaminase," exact="alanine" post="transaminase, bilirubin, C-reactive Protein [CRP], fibrinogen and IL-6) that"/>
 <result pre="erythrocyte sedimentation rate, IL-6, lactate dehydrogenase, D-dimer, ferritin, troponin and" exact="creatine" post="kinase-MB. Imaging investigations are typically computed tomography scans: in"/>
 <result pre="in response to tissue damage (elevated levels of D-dimer, ferritin," exact="creatine" post="kinase-MB, and troponin) have been associated with higher mortality"/>
 <result pre="overload. To reduce fever, antipyretic drugs such as paracetamol or" exact="acetaminophen" post="can be administered. Drugs such as remdesivir, chloroquine, ritonavir,"/>
 <result pre="effectiveness has not yet been confirmed.88â€&quot;93 Unfortunately, the use of" exact="chloroquine" post="and derivatives such as hydroxychloroquine, alone or in combination"/>
 <result pre="is currently in phase 2 clinical trials. The protein inhibitor" exact="ritonavir" post="has also been proposed for the treatment of COVID-19."/>
 <result pre="of cellular stress responses.99 The ligands haloperidol, PB28, PD-144418, and" exact="hydroxychloroquine" post="are currently undergoing clinical trials in COVID-19 patients.100 These"/>
 <result pre="after viral entry has occurred. The lack of selectivity of" exact="chloroquine" post="and hydroxychloroquine, including off-target effects on the human Ether-Ã"/>
 <result pre="84LiJYDuanXFWangLP, et al.Selective depletion of regulatory T cell subsets by" exact="docetaxel" post="treatment in patients with non-small cell lung cancer. J"/>
 <result pre="2019-new coronavirus (2019-nCoV).Biosci Trends2020; 14: 69â€&quot;71.31996494 89WangMCaoRZhangL, et al.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
 <result pre="coronavirus SARS-CoV-2. Int J Antimicrob Agents2020; 55: 105923.32070753 93KapoorKMKapoorA.Role of" exact="chloroquine" post="and hydroxychloroquine in the treatment of COVID-19 infection â€&quot;"/>
 <result pre="Int J Antimicrob Agents2020; 55: 105923.32070753 93KapoorKMKapoorA.Role of chloroquine and" exact="hydroxychloroquine" post="in the treatment of COVID-19 infection â€&quot; a systematic"/>
 <result pre="â€&quot; a systematic literature review. medRxiv2020. 94MehraMRDesaiSSRuschitzkaF, et al.Hydroxychloroquine or" exact="chloroquine" post="with or without a macrolide for treatment of COVID-19:"/>
 <result pre="congenital microcephaly in mice.EBioMedicine2017; 24: 189â€&quot;194.29033372 96LiuXChenGShangY, et al.Efficacy of" exact="chloroquine" post="versus lopinavir/ritonavir in mild/general COVID-19 infection: A prospective, open-label,"/>
 <result pre="vitro antiviral activity and projection of optimized dosing design of" exact="hydroxychloroquine" post="for the treatment of severe acute respiratory syndrome coronavirus"/>
 <result pre="Commun2011; 415: 519â€&quot;525.22079628 100ThompsonBT. Outcomes related to COVID-19 treated with" exact="hydroxychloroquine" post="among in-patients with symptomatic disease. https://clinicaltrialsgov/ct2/show/NCT04332991. 2020. 101WhiteNJ.Cardiotoxicity of"/>
</results>
